Person:
Azanza Álvarez, Paula

Profile Picture

Email Address

person.page.identifierURI

https://academica-e.unavarra.es/handle/2454/48633

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Azanza Álvarez

First Name

Paula

person.page.departamento

Derecho Público

person.page.instituteName

ORCID

person.page.upna

810996

Name

Filters

20171
Reset filters

Settings

Start date: 2017 × End date: 2017 × Subject: Differential profile ×

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    PublicationOpen Access
    Gender differences in treatment progress of drug-addicted patients
    (Taylor & Francis, 2017) Fernández-Montalvo, Javier; López-Goñi, José Javier; Azanza Álvarez, Paula; Arteaga Olleta, Alfonso; Cacho Fernández, Raúl; Psicología y Pedagogía; Psikologia eta Pedagogia; Gobierno de Navarra / Nafarroako Gobernua
    This study explored the differences in treatment progress between men and women who were addicted to drugs. The differential rate of completion of/dropout from treatment in men and women with substance dependence was established. Moreover, comparisons between completers and dropouts, accounting for gender, were carried out for several variables related to treatment progress and clinical profile. A sample of 183 addicted patients (96 male and 87 female) who sought outpatient treatment between 2002 and 2006 was assessed. Information on socio-demographic, consumption and associated characteristics was collected. A detailed tracking of each patient's progress was maintained for a minimum period of eight years to assess treatment progression. The treatment dropout rate in the whole sample was 38.8%, with statistically significant differences between women (47.1%) and men (31.3%). Women who dropped out of treatment presented a more severe profile in most of the psychopathologic variables than women who completed it. Moreover, women who dropped out from treatment presented a more severe profile than men who dropped out. According to these results, drug-addicted women showed worse therapeutic progress than men with similar histories. Thus, women must be provided with additional targeted intervention to promote better treatment outcomes.